The case for therapeutic vaccines
Melanoma Res
.
1996 Feb;6(1):5-10.
doi: 10.1097/00008390-199602000-00002.
Author
A Dalgleish
1
Affiliation
1
Division of Oncology, Department of Cellular and Molecular Sciences, St. George's Hospital Medical School, London, UK.
PMID:
8640070
DOI:
10.1097/00008390-199602000-00002
No abstract available
Publication types
Review
MeSH terms
Clinical Trials as Topic
Humans
Immunotherapy, Active*
Melanoma / therapy*